New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – MARRONE BIO INNOVATIONS INC (0001441693) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – MARRONE BIO INNOVATIONS INC (0001441693) (Filer)
Filed: 2016-01-13 AccNo: 0001193125-16-429026 Size: 14 KB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 8.01: Other Events
Filing Date: 2016-01-13T17:11:02-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1441693/000119312516429026/0001193125-16-429026-index.htm